FDA set to approve a new Alzheimer’s drug for the first time in nearly 20 years
FDA set to approve a new Alzheimer’s drug – a first in nearly 20 years – by March after Biogen showed its treatment may slow the progress of the memory disease U.S. regulators will review the drug, called aducanumab, for approval on Friday They released documents on the treatment on Wednesday and said the drug’s … Read more